SCHEDULE 13G/A
0002005369
XXXXXXXX
LIVE
1
Common Stock, $0.001 par value per share
12/31/2025
0001509261
Rezolute, Inc.
76200L309
275 Shoreline Drive, Suite 500
Redwood City
CA
94065
Rule 13d-1(c)
Invus Public Equities, L.P.
D0
0.00
0.00
0.00
0.00
0.00
N
0
PN
Invus Public Equities Advisors, LLC
DE
0.00
0.00
0.00
0.00
0.00
N
0
OO
Invus Global Management, LLC
DE
0.00
0.00
0.00
0.00
0.00
N
0
OO
Siren, L.L.C.
DE
0.00
0.00
0.00
0.00
0.00
N
0
OO
Avicenna Life Sci Master Fund LP
E9
0.00
0.00
0.00
0.00
0.00
N
0
PN
Avicenna Life Sci Master GP LLC
DE
0.00
0.00
0.00
0.00
0.00
N
0
OO
Ulys, L.L.C.
DE
0.00
0.00
0.00
0.00
0.00
N
0
OO
Raymond Debbane
R1
0.00
0.00
0.00
0.00
0.00
N
0
IN
Rezolute, Inc.
275 Shoreline Drive, Suite 500, Redwood City, CA 94065
See Item 2(c) below.
See Item 2(c) below.
(i) Invus Public Equities, L.P. ("Invus Public Equities")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Bermuda limited partnership
(ii) Invus Public Equities Advisors, LLC ("Invus PE Advisors")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(iii) Invus Global Management, LLC ("Global Management")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(iv) Siren, L.L.C. ("Siren")
c/o The Invus Group, LLC, 750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(v) Avicenna Life Sci Master Fund LP ("Avicenna Fund")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Cayman Islands limited partnership
(vi) Avicenna Life Sci Master GP LLC ("Avicenna GP")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(vii) Ulys, L.L.C. ("Ulys")
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
(viii) Mr. Raymond Debbane
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Panama
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
Y
As of December 31, 2025, the Reporting Persons no longer beneficially own any Shares.
As of December 31, 2025, the Reporting Persons no longer beneficially own any Shares.
See each cover page hereof.
See each cover page hereof.
See each cover page hereof.
See each cover page hereof.
N
Y
Y
Y
Y
Y
N
Each of the Reporting Persons hereby makes the following certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Invus Public Equities, L.P.
/s/ Raymond Debbane
Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
02/13/2026
Invus Public Equities Advisors, LLC
/s/ Raymond Debbane
Raymond Debbane, President
02/13/2026
Invus Global Management, LLC
/s/ Raymond Debbane
Raymond Debbane, President
02/13/2026
Siren, L.L.C.
/s/ Raymond Debbane
Raymond Debbane, President
02/13/2026
Avicenna Life Sci Master Fund LP
/s/ Raymond Debbane
Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
02/13/2026
Avicenna Life Sci Master GP LLC
/s/ Raymond Debbane
Raymond Debbane, Chief Executive Officer
02/13/2026
Ulys, L.L.C.
/s/ Raymond Debbane
Raymond Debbane, President
02/13/2026
Raymond Debbane
/s/ Raymond Debbane
Raymond Debbane
02/13/2026